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The Treatment of Mental Disorders through Medication
Jessica Jaynes
Colorado Psychiatry Center is an outpatient mental health center that focuses on
treating a variety of mental disorders through medication. The psychiatrists focus on
getting a diagnosis for each of their patients in order to help them return to a functional,
happy life through treatment [1]. For the summers of 2011 and 2012 I had the
opportunity to intern at Colorado Psychiatry Center. During my time there, I did a variety
of things that exposed me to a number of mental disabilities including anxiety,
depression, bipolar disorder, and ADHD. This experience helped me to gain a better
understanding of how medications are used to target different mental disorders and the
brain areas involved. I also gained an understanding of the importance of mental health
care and how each patient should be looked at as an individual.
Getting a correct diagnosis for a patient is crucial in their recovery. Sometimes
this can be difficult because symptoms of mental disabilities are variable for different
patients. Some patients exhibit symptoms more than others, and some even exhibit
different symptoms. While interning at the psychiatrist office I was also able to shadow
the doctor and PAs. This was a very valuable experience that allowed me to witness
firsthand what some mental disabilities look like, including some of the symptoms
associated with different disorders. After the initial appointments with patients, the
doctors would often discuss with me what diagnosis they were going to make, plus
some of the symptoms that the patient complained of that gave them reason to believe
in their diagnosis. For example, patients with ADHD will have a hard time having a
continuous train of thought [2, 3]. Patients with bipolar disorder will experience feelings
of grandiosity, risky behavior, and restlessness when they are having a manic episode,
but also experience times of depression [4, 5]. Depression consists of trouble sleeping,
a saddened mood, and potentially suicidal thoughts [6]. When diagnosing, it is important
to identify key characteristics of mental disorders as well as be able to differentiate
between mental disorders that are have similar symptoms. For example, a doctor needs
to distinguish bipolar disorder from depression during the initial diagnosis by finding out
whether or not the patient experiences manic episodes. Knowing some of the most
common symptoms is crucial to a good diagnosis.
Once a diagnosis has been obtained, patients can be treated. At Colorado
Psychiatry Center, treatment is generally done with medication. To prescribe these
medications, the doctors at Colorado Psychiatry Center have an algorithm that they
follow—meaning that there is a hierarchy of drugs that should be prescribed. Not every
drug is effective for every patient, so if the first medication does not work, the
psychiatrist will move on to the next one in the algorithm, which will have a different
target within the brain. Most medications for mental disabilities work by acting on
neurotransmitters inside the brain. Neurotransmitters are chemicals that transmit signals
from a neuron to a target cell across a synapse [7]. Once across a synapse,
neurotransmitters then can bind to receptors, which will generally cause an action
potential that will propagate an electrical signal through the axon [8]. Some of the most
common neurotransmitters involved in mental disabilities include serotonin, dopamine,
and norepinephrine. Serotonin regulates appetite, sleep, learning, mood, and behavior
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[9, 10]; dopamine is involved in the reward system [11]; and norepinephrine has also
been found to affect the reward system, alertness and arousal [12].
While shadowing at Colorado Psychiatry Center, I was also responsible for filling
prescription refill requests. This experience helped me become familiar with what was
commonly prescribed for different mental disabilities. In depression, there are low levels
of serotonin and dopamine [13], so medication for patients with depression targets
these neurotransmitters. Some of the most common medications prescribed are
wellbutrin and sertraline. Wellbutrin is a drug that increases the concentration of
dopamine [14], while sertraline blocks the reuptake of serotonin to enhance its
functional activity. If one of these drugs is not working effectively the other will be
prescribed and most likely work because they act on different systems.
Patients with bipolar disorder are most often treated with Lithium because it
treats both the manic and depressive phases. It is a mood-stabilizing drug that both
decreases norepinephrine release and increases serotonin synthesis. This is very
effective because it targets both the high concentration of norepinephrine and low levels
of serotonin found in patients with bipolar disorder [15].
ADHD is most commonly treated with Concerta, Adderall, or Focalin. These are
stimulants that increase the low levels of dopamine and norepinephrine. In patients with
ADHD, the low levels of norepinephrine are associated with their inattentiveness and
the low levels of dopamine lead to impulsivity problems. All of these drugs have different
strengths and side effects, so whatever medication works best for a particular patient is
what is used [16].
It is important to remember that there are particular areas within the brain that
are impacted by mental disabilities. It helps to understand different areas of the brain to
get a better idea of what is going on in each mental disability and how the symptoms
arise. The amygdala is a brain area which plays a large role in many disorders, one
being anxiety. The amygdala is a brain area within the limbic system that functions in
emotional processing, especially in the perception of fear. Patients with anxiety and
social phobias have an over-responsive amygdala due to their imbalance of
neurotransmitters. An over-responsive amygdala would most likely cause anxiety
because more things will elicit a fear response in the brain. The neurons within the
amygdala will fire more often, signaling other areas of the brain that you should be
scared [17].
Another example of understanding mental disabilities by looking at the brain
areas involved is ADHD. Patients with ADHD have problems within their frontal lobe.
The frontal lobe is an area of the brain that is responsible for attention, planning,
motivation, and rewards. This helps to explain the symptoms found in those with ADHD;
they have a lack of motivation and attention. Furthermore, the area within the frontal
lobe that controls and inhibits behavior is underactive in patients with ADHD. This
explains the impulsivity seen in ADHD [2].
When treating mental disabilities it is important to see the patient as an individual
rather than as their disorder. Each patient is different, but once the treatment plan is
figured out, it makes a huge difference. After the correct diagnosis is reached,
psychiatrists use their knowledge of neurotransmitters and brain areas involved in the
disorder to help prescribe medication for their patient. These medications are often very
successful, and it is wonderful to witness improvement in the lives of the patients as

http://soundideas.pugetsound.edu/soundneuroscience/vol1/iss2/9

2

Jaynes: The Treatment of Mental Disorders through Medication

they recover. Although treatment with medication works for many individuals, it doesn’t
work for all. There are some patients that do not want to go on medication, or are not
responding to their treatment. In these cases, patients are referred to psychologists:
This method of treatment can also be very helpful.
I really appreciate the opportunity I had to intern at Colorado Psychiatry Center. I
learned a lot about mental disabilities, which was extremely valuable. However, I think
the most satisfying part was being able to witness the recovery of patients. Mental
disabilities can severely impact the lives of those involved, so being able to see patients
improve while being treated was exceedingly refreshing and rewarding.
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